Supporting a causal role for Akt activation in MFS aortopathy, our data indicate that pharmacological mTOR/Akt inhibition rapidly reverses aortic dilation and decreases Nos2 levels in MFS mice. The gene discussed is MTOR; the disease is Marfan syndrome.